Shoulder Innovations, INC Form 4 insider transactions

Healthcare Holding B.V. Gilde, a 10% owner of Shoulder Innovations, Inc., sold 9,433 shares of common stock on August 5, 2026.

Healthcare Holding B.V. Gilde, a 10% owner of Shoulder Innovations, Inc., sold 110,563 shares of common stock on August 3, 2026.

Healthcare Holding B.V. Gilde, a 10% owner of Shoulder Innovations, Inc., sold 48,279 shares of common stock on July 30, 2026.

Casey M. Tansey, a Director and 10% owner of Shoulder Innovations, Inc. (SI), reported the acquisition of 5,046 shares of common stock on June 26, 2026.

Kevin K. Sidow, a Director at Shoulder Innovations, Inc., acquired 5,046 restricted stock units on June 26, 2026, as part of a compensation award.

Andrew Hykes, a Director at Shoulder Innovations, Inc., acquired 5,046 shares of common stock through an award of restricted stock units.

Paul Buckman, a Director at Shoulder Innovations, Inc., acquired 5,046 restricted stock units (RSUs) on June 26, 2026, as part of an award.

Richard Buchholz, a Director at Shoulder Innovations, Inc., acquired 5,046 restricted stock units.

Matthew Ahearn, Chief Operating Officer of Shoulder Innovations, Inc., reported the sale of company stock totaling over $18 million through a pre-arranged trading plan.

CEO and Executive Chairman Robert Ball exercised 10,000 stock options in Shoulder Innovations, Inc. on April 30, 2026.

Chief Operating Officer Matthew Ahearn exercised stock options to acquire 21,664 shares of Shoulder Innovations common stock.

Shoulder Innovations CFO Jeffrey Points acquired additional common stock and exercised options, increasing his direct beneficial ownership.

Paul Buckman, a Director at Shoulder Innovations, Inc., exercised stock options and increased his direct common stock holdings on March 13, 2026.

A director at Shoulder Innovations, Inc. has purchased 1,000 shares of common stock, signaling confidence in the company's future.

SHOULDER INNOVATIONS' CEO and Executive Chairman, Robert Joseph Ball, acquired 2,200 shares of common stock at an average price of $15.1782 per share.

Shoulder Innovations' CEO and Executive Chairman, Robert Joseph Ball, exercised stock options to acquire 12,062 shares of common stock.

Shoulder Innovations' Chief Financial Officer, Jeffrey S. Points, was granted 126,357 stock options with an exercise price of $14.16.

SHOULDER INNOVATIONS, INC. officer David Lawrence Blue was granted 88,450 stock options with an exercise price of $14.16, vesting annually starting March 2027.

SHOULDER INNOVATIONS CEO Robert Joseph Ball acquired 265,351 stock options with an exercise price of $14.16, vesting annually starting March 1, 2027.

SHOULDER INNOVATIONS, INC. Chief Operating Officer Matthew Fraser Ahearn was granted 88,450 stock options with an exercise price of $14.16.

Shoulder Innovations CFO Jeffrey S. Points acquired 1,076 shares of common stock through the company's 2025 Employee Stock Purchase Plan.

SHOULDER INNOVATIONS, INC. Chief Customer Experience Officer David Lawrence Blue acquired 1,041 shares of common stock through the company's Employee Stock Purchase Plan.

SHOULDER INNOVATIONS, INC. CEO Robert Joseph Ball acquired 1,661 shares of common stock through the company's Employee Stock Purchase Plan at a discounted price.

Shoulder Innovations' Chief Operating Officer, Matthew Ahearn, acquired 477 shares of common stock through the company's Employee Stock Purchase Plan.

Jeffrey S. Points, Chief Financial Officer of Shoulder Innovations, Inc., reported open market purchases of common stock totaling 2,000 shares in December 2025.

Robert Joseph Ball, CEO and Executive Chairman of Shoulder Innovations, Inc., purchased 7,200 shares of common stock for approximately $107,109 across two transactions in December 2025.

Shoulder Innovations' CFO, Jeffrey S. Points, increased his direct beneficial ownership through both stock option exercise and open market purchases.

SHOULDER INNOVATIONS' Chief Customer Experience Officer, David Lawrence Blue, exercised stock options for 94,394 shares of common stock.

SHOULDER INNOVATIONS CEO and Executive Chairman Robert Joseph Ball increased his direct ownership in the company by purchasing 8,000 shares of common stock over two days in September 2025.

Matthew Fraser Ahearn, Chief Operating Officer of SHOULDER INNOVATIONS, acquired 107,345 shares of common stock through option exercises on September 11, 2025, increasing his total beneficial ownership to 215,379 shares.